
Novo Nordisk A/S / Fundamentals
Income statement
- Net revenue
€41.77B - Cost of goods sold
€6.70B - Gross profit
€35.06B - SG&A expenses
€9.62B - R&D expenses
€6.06B - EBITDA
€22.58B - D&A
€2.46B - EBIT
€19.13B - Interest expenses
€1.47B - EBT
€18.85B - Tax expenses
€3.98B - Net income
€14.87B
Cash flow statement
- Net deferred tax
€2.26B - Non-cash items
-€104.98M - Changes in working capital
-€3.20B - Operating cash flow
€16.27B - Capex
€7.97B - Other investing cash flow
-€433.29M - Net investing cash flow
-€17.81B - Total cash dividends paid
-€6.79B - Issuance of common stock
€0.00 - Debt repayment
-€629.85M - Other financing cash flow
€5.94B - Net financing cash flow
-€2.99B - Foreign exchange effects
-€70.56M - Net change in cash
-€4.60B - Cash at end of period
€2.47B - Free cash flow
€24.24B
Balance sheet
- Cash and cash equivalents
€2.47B - Cash and short-term investments
€2.54B - Total receivables
€11.49B - Inventory
€6.11B - Other current assets
€1.64B - Total current assets
€21.79B - Property, plant & equipment
€24.20B - Goodwill
€0.00 - Intangible assets
€14.44B - Long-term investments
€353.22M - Other non-current assets
€594.37M - Total non-current assets
€42.77B - Total assets
€64.56B - Accounts payable
€3.78B - Short-term debt
€1.60B - Other current liabilities
€20.14B - Total current liabilities
€27.79B - Long-term debt
€11.69B - Deferred tax liabilities
€1.31B - Other non-current liabilities
€1.27B - Total non-current liabilities
€14.27B - Total liabilities
€42.06B - Common stock
€59.72M - Retained earnings
€22.02B - Other equity
€424.32M - Total equity
€22.50B - Total liabilities and shareholders' equity
€64.56B
Company information
- Market capitalization
€258.73B - Employees
77K - Enterprise Value
€2.39T
Company ratios
- Gross margin
-
83.9% Much better than peer group: -187,944.4% - EBITDA margin
-
54.1% Much better than peer group: -3,612.5% - EBIT margin
-
45.8% Much better than peer group: -3,799.7% - EBT margin
-
45.1% Much better than peer group: -19,051.0% - Net margin
-
35.6% Much better than peer group: -3,814.2% - ROE
-
66.1% Much better than peer group: -28.4% - ROA
-
23.0% Much better than peer group: -49.9% - Asset turnover
-
64.7% Much better than peer group: 23.9% - FCF margin
-
19.9% Much better than peer group: -2,881.7% - FCF yield
3.2% - Efficiency ratio
45.9% - Net sales per employee
-
€539.59K - Net income per employee
-
€192.13K